WITNESSETH:Consulting Agreement • September 10th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Exhibit 4.1 OPTION AGREEMENT THIS OPTION AGREEMENT (this "AGREEMENT") dated as of this __ of June, 2001, is hereby entered into by and between [___________], a [__________] [LIMITED PARTNERSHIP] (the "SELLER"), Alliance Pharmaceutical Corp., a New...Option Agreement • June 26th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of August 13, 1998, among Alliance Pharmaceutical Corp., a New York corporation (the "COMPANY"), Brown Simpson Strategic Growth Fund, L.P.,...Registration Rights Agreement • September 11th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
LICENSE AGREEMENT originally dated as of September 23, 1997 amended and restated in its entirety as of February 22, 2002License Agreement • May 15th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
ASSET PURCHASE AGREEMENT Dated June __, 2003 By and between Photogen Technologies, Inc.Asset Purchase Agreement • June 23rd, 2003 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
FORM OF 6% CONVERTIBLE NOTE DUE 2005Alliance Pharmaceutical Corp • February 14th, 2001 • In vitro & in vivo diagnostic substances
RECITALSCommon Stock Purchase Agreement • November 19th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
RECITALSSupply Agreement • February 14th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Texas
FORM OFAlliance Pharmaceutical Corp • May 18th, 2000 • In vitro & in vivo diagnostic substances • New York
Exhibit 10(ww) ALLIANCE/PFC SECURITY AGREEMENT THIS ALLIANCE/PFC SECURITY AGREEMENT (this "Security Agreement") is made as of this 19th day of May, 2000, by and between Alliance Pharmaceutical Corp., a New York corporation (the "Debtor"), and PFC...Security Agreement • September 1st, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
AMENDMENT NO. 2License Agreement • February 14th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
AGREEMENTAgreement • May 15th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Ohio
CONFIDENTIAL TREATMENT REQUESTED EXHIBIT 10.77 CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24(b)(2) OF THE SECURITIES AND EXCHANGE ACT OF 1934. CONFIDENTIAL TREATMENT REQUESTED IS REQUESTED AND IS NOTED WITH "[CONFIDENTIAL TREATMENT REQUESTED]." AN...Agreement • February 14th, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
Exhibit 10(b) COLLATERAL ASSIGNMENT OF LIFE INSURANCE POLICY THIS ASSIGNMENT is made effective this 25th day of November, 1998, by and between ALLIANCE PHARMACEUTICAL CORPORATION (hereinafter "APC"), and DUANE JOSEPH ROTH (hereinafter referred to as...Alliance Pharmaceutical Corp • November 10th, 1999 • In vitro & in vivo diagnostic substances
ARTICLE 1 DEFINITIONSLicense Agreement • November 19th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
LICENSE AGREEMENTLicense Agreement • September 1st, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Illinois
DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT BETWEEN PFC THERAPEUTICS, LLC AND BEIJING DOUBLE-CRANE PHARMACEUTICAL CO., LTD.Confidential Treatment • September 28th, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10(b) CONSULTING AGREEMENT THIS CONSULTING AGREEMENT made as of this 1st day of July, 2000 (the "Agreement") by and between Alliance Pharmaceutical GmbH, a German corporation (the "Company") and Jean Riess, whose address is Les Giaines, 06950...Consulting Agreement • February 14th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
LOGO] CREDIT AGREEMENTCredit Agreement • September 11th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
VOTING AGREEMENTVoting Agreement • November 9th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Delaware
COMMON STOCKUnderwriting Agreement • March 28th, 1996 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
INTELLECTUAL PROPERTY SECURITY AGREEMENT (Borrower as Grantor)Intellectual Property Security Agreement • September 28th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
08-02-99 COMMERCIAL SECURITY AGREEMENT PAGE 2 (CONTINUED)Security Agreement • September 28th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
ARTICLE 1 DEFINITIONSLicense Agreement • November 19th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
WITNESSETH:Consulting Agreement • May 15th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Exhibit 4.2 SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 28th, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Exhibit 10(d) COLLATERAL ASSIGNMENT OF LIFE INSURANCE POLICY THIS ASSIGNMENT is made effective this 12th day of November, 1998, by and between ALLIANCE PHARMACEUTICAL CORPORATION (hereinafter "APC"), and THEODORE D. ROTH (hereinafter referred to as...Alliance Pharmaceutical Corp • November 10th, 1999 • In vitro & in vivo diagnostic substances
Exhibit 10(a) SEVERANCE AGREEMENT AND RELEASE THIS SEVERANCE AGREEMENT AND RELEASE ("Agreement"), effective the 31st day of January, 2001, is entered into between ARTEMIOS B. VASSOS, M.D., F.A.C.P. ("Employee") and ALLIANCE PHARMACEUTICAL CORP., a New...Severance Agreement and Release • May 15th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
WITNESSETH THAT:Split Dollar Life Insurance Agreement • November 10th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
RECITALSMarketing and Distribution Agreement • September 1st, 2000 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Illinois
Exhibit 99.2(a) ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 19th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
WITNESSETH THAT:Dollar Life Insurance Agreement • November 10th, 1999 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
CONFIDENTIAL TREATMENT REQUESTED EXHIBIT 10.78 CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24(b)(2) OF THE SECURITIES AND EXCHANGE ACT OF 1934. CONFIDENTIAL TREATMENT REQUESTED IS REQUESTED AND IS NOTED WITH "[CONFIDENTIAL TREATMENT REQUESTED]." AN...Exclusivity Agreement • May 16th, 2005 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
ANDAgreement and Plan • November 20th, 1996 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Delaware
LICENSE AGREEMENTLicense Agreement • February 27th, 1998 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
